Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros

Métodos Terapéuticos y Terapias MTCI
Bases de datos
Tipo de estudio
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Gut ; 52(6): 813-9, 2003 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-12740336

RESUMEN

BACKGROUND: We previously reported that gastrin induces expression of CXC chemokines through activation of nuclear factor kappaB (NFkappaB) in gastric epithelial cells that express gastrin receptor. AIMS: To clarify gastrin receptor mediated signals leading to activation of NFkappaB. METHODS: MKGR26 cells were created by transfecting gastrin receptor cDNA into MKN-28 cells. Degradation of inhibitor kappaB (IkappaB) and phosphorylation of protein kinase C (PKC)-delta were both detected by western blot analysis. NFkappaB activation was determined by luciferase assay and electrophoretic mobility shift analysis. RESULTS: Gastrin induced degradation of IkappaB-alpha and activation of NFkappaB, which was abolished by the selective gastrin receptor antagonist L-740,093 and the general PKC inhibitor GF109203X. Gastrin induced phosphorylation of PKC-delta, and its inhibitor rottlerin partially suppressed NFkappaB activation. However, the mitogen activated protein kinase (MAPK) kinase inhibitor PD98059, p38 MAPK inhibitor SB203580, and tyrphostin AG1478 had no effect on NFkappaB activation. Introduction of the dominant negative mutant of IkappaB kinase, of NFkappaB inducing kinase, and of tumour necrosis factor receptor associated factor 6 (TRAF6), but not that of TRAF2, inhibited gastrin induced activation of NFkappaB. CONCLUSIONS: Gastrin activates NFkappaB via a PKC dependent pathway which involves IkappaB kinase, NFkappaB inducing kinase, and TRAF6.


Asunto(s)
Mucosa Gástrica/efectos de los fármacos , Gastrinas/farmacología , FN-kappa B/metabolismo , Proteína Quinasa C/fisiología , Proteínas/fisiología , Animales , Western Blotting , Línea Celular , ADN Complementario/genética , Mucosa Gástrica/citología , Mucosa Gástrica/metabolismo , Cobayas , Humanos , FN-kappa B/antagonistas & inhibidores , Fosforilación , Proteína Quinasa C/antagonistas & inhibidores , Proteínas Serina-Treonina Quinasas/fisiología , Receptores de Colecistoquinina/antagonistas & inhibidores , Receptores de Colecistoquinina/genética , Receptores de Colecistoquinina/fisiología , Transducción de Señal/efectos de los fármacos , Factor 6 Asociado a Receptor de TNF , Transfección , Células Tumorales Cultivadas , Quinasa de Factor Nuclear kappa B
2.
Gastroenterology ; 120(1): 108-16, 2001 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-11208719

RESUMEN

BACKGROUND & AIMS: Epidermal growth factor (EGF)-like growth factors are induced after acute gastric injury and may play an important role in mucosal repair. However, the mechanisms that trigger these growth factors are poorly understood. We determined the role of EGF receptor (EGFR) in stress-induced expression of heparin-binding EGF-like growth factor (HB-EGF) in a rat gastric epithelial cell line (RGM1 cells). METHODS: RGM1 cells were transfected with a plasmid containing complementary DNA encoding a dominant-negative human EGFR (HERCD533). Cells were treated with hydrogen peroxide (0-400 micromol/L) or sorbitol (600 mmol/L). Tyrosine phosphorylation of EGFR was determined by immunoprecipitation and Western blotting with an antiphosphotyrosine antibody. HB-EGF messenger RNA and protein were determined with Northern and Western blotting, respectively. Cell growth was evaluated by cell number and [(3)H]thymidine incorporation. RESULTS: Oxidative stress and osmotic stress induced tyrosine phosphorylation of EGFR within 2 minutes, followed by a marked increase in HB-EGF and amphiregulin transcripts in RGM1 cells. Introduction of HERCD533 into the cells inhibited not only tyrosine phosphorylation of EGFR but also growth response to EGF. Furthermore, oxidative stress-induced HB-EGF messenger RNA expression was impaired in HERCD533-expressing cells. CONCLUSIONS: EGFR plays a crucial role in the stress-induced expression of EGF-like growth factors in gastrointestinal epithelial cells.


Asunto(s)
Factor de Crecimiento Epidérmico/genética , Receptores ErbB/genética , Receptores ErbB/metabolismo , Mucosa Gástrica/metabolismo , Péptidos y Proteínas de Señalización Intercelular , Estrés Oxidativo/fisiología , Anfirregulina , Animales , Western Blotting , Medio de Cultivo Libre de Suero/farmacología , ADN Complementario , Familia de Proteínas EGF , Factor de Crecimiento Epidérmico/análisis , Factor de Crecimiento Epidérmico/metabolismo , Factor de Crecimiento Epidérmico/farmacología , Mucosa Gástrica/citología , Mucosa Gástrica/efectos de los fármacos , Regulación de la Expresión Génica/efectos de los fármacos , Regulación de la Expresión Génica/fisiología , Glicoproteínas/genética , Sustancias de Crecimiento/genética , Factor de Crecimiento Similar a EGF de Unión a Heparina , Ligandos , Fosforilación , Regiones Promotoras Genéticas/fisiología , Proteínas Proto-Oncogénicas c-met/metabolismo , ARN Mensajero/metabolismo , Ratas , Ratas Wistar , Receptor ErbB-2/metabolismo , Receptor ErbB-3/metabolismo , Transfección , Factor de Crecimiento Transformador alfa/genética , Tirosina/metabolismo
3.
Gastroenterology ; 116(1): 78-89, 1999 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-9869605

RESUMEN

BACKGROUND & AIMS: Parietal cells express heparin-binding epidermal growth factor (EGF)-like growth factor (HB-EGF). However, it is unknown whether HB-EGF mediates the trophic action of gastrin. The purpose of this study was to determine whether gastrin modulates the expression of HB-EGF, which mediates the proliferative effects of gastrin on gastric epithelial cells. METHODS: RGM1 cells, a rat gastric epithelial cell line, were transfected with a human gastrin receptor complementary DNA. Gastrin induction of messenger RNAs (mRNAs) for EGF-related polypeptides was assayed by Northern blotting. Processing of cell surface-associated proHB-EGF and secretion of HB-EGF were determined by flow cytometry and Western blotting, respectively. Tyrosine phosphorylation of the EGF receptor was assayed by immunoprecipitation and Western blotting with an antiphosphotyrosine antibody. Cell growth was evaluated by [3H]thymidine incorporation. RESULTS: Gastrin induced expression of HB-EGF mRNA, processing of proHB-EGF, release of HB-EGF into the medium, and tyrosine phosphorylation of the EGF receptor. The growth-stimulatory effects of gastrin were partly inhibited by anti-rat HB-EGF serum and completely blocked by AG1478, an EGF receptor-specific tyrphostin. CONCLUSIONS: The findings suggest that HB-EGF at least partially mediates the proliferative effects of gastrin on gastric epithelial cells.


Asunto(s)
Factor de Crecimiento Epidérmico/biosíntesis , Células Epiteliales/metabolismo , Mucosa Gástrica/metabolismo , Gastrinas/farmacología , Heparina/metabolismo , Receptores de Colecistoquinina/biosíntesis , Animales , Northern Blotting , Western Blotting , División Celular/efectos de los fármacos , Línea Celular , Factor de Crecimiento Epidérmico/metabolismo , Células Epiteliales/efectos de los fármacos , Mucosa Gástrica/citología , Mucosa Gástrica/efectos de los fármacos , Cobayas , Factor de Crecimiento Similar a EGF de Unión a Heparina , Humanos , Péptidos y Proteínas de Señalización Intercelular , Masculino , Células Parietales Gástricas/efectos de los fármacos , Células Parietales Gástricas/metabolismo , Fosforilación , Pruebas de Precipitina , ARN Mensajero/biosíntesis , Ratas , Receptor de Colecistoquinina B , Receptores de Colecistoquinina/genética , Transfección , Tirosina/metabolismo
4.
Inflamm Res ; 46(3): 103-7, 1997 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-9098723

RESUMEN

OBJECTIVE AND METHODS: The effect of phospholipase A2 (PLA2) and its phospholipid metabolites on gastric epithelial migration was examined using an in vitro wounding model of confluent monolayers of rat gastric epithelial cell line RGM-1. RESULTS: Lysophosphatidylcholine (lysoPC) (0.01 100 ng/ml) as well as PLA2 (0.01-100 mU/ml) dose-dependently increased the cell migration. Lysophosphatidic acid (10 ng/ml) also increased the migration, but no significant increase in migration was observed when stimulated by lysophosphatidylethanolamine (10 ng/ml) or lysophosphatidylserine (10 ng/ml). Addition of 4-bromophenacyl bromide (BPB), a PLA2 inhibitor, completely blocked the effect of PLA2. However, addition of piroxicam (a cyclooxygenase inhibitor) or nordihydroguaiaretic acid (a lipoxygenase inhibitor) had no significant effect. Combination of PLA2 (10 mU/ml) with lysoPC (10 ng/ml) had no additive effect on migration. Moreover, lysoPC levels were increased in the cells after incubation with PLA2 (10 mU/ml). After pretreatment of RGM-1 cells with replication-inhibiting doses of mitomycin C. PLA2 and lysoPC still increased the cell migration. CONCLUSIONS: These data suggest that PLA2 may, independently of proliferation, increase gastric epithelial migration mainly via lysoPC production.


Asunto(s)
Movimiento Celular/efectos de los fármacos , Mucosa Gástrica/efectos de los fármacos , Fosfolipasas A/farmacología , Acetofenonas/farmacología , Animales , Línea Celular , Inhibidores de la Ciclooxigenasa/farmacología , Evaluación Preclínica de Medicamentos , Inhibidores Enzimáticos/farmacología , Mucosa Gástrica/lesiones , Lisofosfatidilcolinas/análisis , Lisofosfolípidos/farmacología , Masoprocol/farmacología , Fosfolipasas A/antagonistas & inhibidores , Fosfolipasas A2 , Piroxicam/farmacología , Ratas , Estimulación Química
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA